Already a subscriber?
Log In
Become a member to see contact information for Gut microbiota diversity and mortality in pediatric allo-HSCT; C5 inhibition in atypical HUS; and pembrolizumab plus vorinostat in PD-1-refractory Hodgkin lymphoma.
Cast | + Add Cast |
| 0 cast members |
Contribute to this section by adding a cast member